Kaiser Peter 4
4 · OCULAR THERAPEUTIX, INC · Filed Oct 4, 2024
Insider Transaction Report
Form 4
Kaiser Peter
Chief Development Officer
Transactions
- Award
Common Stock
2024-10-02+100,000→ 215,984 total - Award
Stock Option (Right to Buy)
2024-10-02+200,000→ 200,000 totalExercise: $9.31Exp: 2034-10-01→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]On October 2, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on October 1, 2025.
- [F2]Vests over four years, with 1/48 of the shares vesting monthly beginning on November 1, 2024.